CLINICAL TRIALS PROFILE FOR HALOPERIDOL LACTATE

All Clinical Trials for haloperidol lactate

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01139463 ↗	Study of Blood Lactate Levels in Patients Treated With Antipsychotics	Completed	University Hospital of Split		2008-06-01	Blood lactate levels in patients receiving typical or atypical antipsychotics have not been described in the literature. The goal of this study is to assess the dynamics of lactate levels in the blood from typical or atypical antipsychotics not confounded by prior antipsychotic treatments, the investigators conducted a prospective study of lactate levels in patients receiving antipsychotic medication. The investigators hypothesized that 6 months of treatment with haloperidol or olanzapine would result in a change in blood lactate levels and extrapyramidal side effects.
NCT01139463 ↗	Study of Blood Lactate Levels in Patients Treated With Antipsychotics	Completed	University of Split		2008-06-01	Blood lactate levels in patients receiving typical or atypical antipsychotics have not been described in the literature. The goal of this study is to assess the dynamics of lactate levels in the blood from typical or atypical antipsychotics not confounded by prior antipsychotic treatments, the investigators conducted a prospective study of lactate levels in patients receiving antipsychotic medication. The investigators hypothesized that 6 months of treatment with haloperidol or olanzapine would result in a change in blood lactate levels and extrapyramidal side effects.
NCT02807467 ↗	Influence of Dexmedetomidine or Propofol on ICU Delirium	Recruiting	University Hospital, Basel, Switzerland	Phase 4	2019-03-01	In this randomized study, the investigators aim to test the hypothesis that the reinstitution of a normal circadian rhythm by continuous infusions of dexmedetomidine compared to propofol between 8pm and 6am after diagnosis of hyperactive or mixed delirium, decreases the duration of delirium. The infusions might have to be repeated several times to achieve resolution of delirium.
NCT03299452 ↗	Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor	Unknown status	Alphacait, LLC	Phase 2	2017-01-01	This is a single-center, open-label, single-arm, non-randomized study designed to evaluate PFS, safety, overall survival (OS), objective response rate (OPR), disease control rate (DCR) and biomarkers of cancer therapy based on Alphacait screening system in subjects with advanced malignant tumor.

Clinical Trial Conditions for haloperidol lactate

Condition Name

Condition Name for haloperidol lactate
Intervention	Trials
Metastatic Cancer	1
Movement Disorders	1
Out-Of-Hospital Cardiac Arrest	1
Post-Cardiac Arrest Syndrome	1

Condition MeSH

Condition MeSH for haloperidol lactate
Intervention	Trials
Pain, Postoperative	1
Neoplasm Metastasis	1
Delirium	1
Syndrome	1

Clinical Trial Locations for haloperidol lactate

Trials by Country

Trials by Country for haloperidol lactate
Location	Trials
Denmark	2
Croatia	1
Pakistan	1
China	1
Switzerland	1

Clinical Trial Progress for haloperidol lactate

Clinical Trial Phase

Clinical Trial Phase for haloperidol lactate
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	1
Phase 2	1

Clinical Trial Status

Clinical Trial Status for haloperidol lactate
Clinical Trial Phase	Trials
Recruiting	2
Unknown status	1
Completed	1

Clinical Trial Sponsors for haloperidol lactate

Sponsor Name

Sponsor Name for haloperidol lactate
Sponsor	Trials
University Hospital, Basel, Switzerland	1
Alphacait, LLC	1
Haining Health-Coming Biotech Co., Ltd.	1

Sponsor Type

Sponsor Type for haloperidol lactate
Sponsor	Trials
Other	7